Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Upconversion nanoparticles (UCNPs) have gained increased attention due to their various medical applications such as drug delivery, detection, imaging, and photodynamic therapy. But little is known about their direct biological activity. In the present study, we synthesized NaYF
4
:Yb,Er UCNPs coated with poly-(allylamine hydrochloride) (
PAH
) or poly(acrylic acid) (PAA) and investigated their effects in human
myeloma
and leukemia cells. When these cells were incubated with both types of UCNPs, we found that
PAH
-UCNPs but not PAA-UCNPs increased the expression of LC3-II, a hallmark of autophagy. This effect was confirmed by the accumulation of LC3 puncta as analyzed by immunofluorescence microscopy. Induction of LC3-II could be blocked by 3-methyl adenosine (3-MA), an autophagy inhibitor. Consistent with this observation,
PAH
-UCNPs also inhibited both AKT and mTOR activation, the key step in autophagy activation. Further studies demonstrated that
PAH
-UCNPs also decreased Bcl-2 but increased Beclin1 and Atg14 expression, suggesting that
PAH
-UCNPs-induced autophagy was associated with increased PI3KC3-Beclin1 activity. Moreover,
PAH
-UCNPs induced apoptosis in
myeloma
cells and enhanced apoptosis induced by bortezomib and doxorubicin, two major anti-
myeloma
drugs. Therefore, our study suggested that
PAH
-UCNPs alone can induce both apoptosis and autophagy in human blood cancer cells by modulating the AKT-mTOR and PI3KC3-Beclin1-Atg14 signaling pathways. This study implies the potential application of
PAH
-UCNPs in blood cancer-cell killing.
...
PMID:Poly-(allylamine hydrochloride)-coated but not poly(acrylic acid)-coated upconversion nanoparticles induce autophagy and apoptosis in human blood cancer cells. 3226 73